PT BUNDAMEDIK TBK |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 312 IDR | -0.64% |
|
-0.64% | -4.29% |
| 03-31 | PT Bundamedik Tbk Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | PT Bundamedik Tbk Reports Earnings Results for the Nine Months Ended September 30, 2023 | CI |
| Sales 2024 * | 1,891B 117M 9.35B | Sales 2025 * | 2,188B 136M 10.82B | Capitalization | 2,684B 166M 13.27B |
|---|---|---|---|---|---|
| Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 1.42 x |
| Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 1.23 x |
| P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 1,434 |
| Yield 2024 * |
0.29% | Yield 2025 * |
0.67% | Free-Float | 21.47% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.64% | ||
| 1 week | -0.64% | ||
| Current month | -9.83% | ||
| 1 month | -10.34% | ||
| 3 months | -1.27% | ||
| 6 months | -20.00% | ||
| Current year | -4.29% |
1 week
296.00
324.00
1 month
296.00350.00
Current year
294.00376.00
1 year
268.00414.00
3 years
268.001 200.00
5 years
268.001 200.00
10 years
268.001 200.00
| Managers | Title | Age | Since |
|---|---|---|---|
Mesha Rizal Sini
CEO | Chief Executive Officer | 50 | 31/12/18 |
| Comptroller/Controller/Auditor | - | - | |
Emilia Rouli
PRN | Corporate Officer/Principal | - | 20/07/22 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 51 | 20/07/22 | |
| Director/Board Member | 54 | 31/12/20 | |
Ivan Rizal Sini
CHM | Chairman | 51 | 31/12/15 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 312 | -0.64% | 55,400 |
| 25/04/24 | 314 | +1.29% | 212,300 |
| 24/04/24 | 310 | -0.64% | 1,274,000 |
| 23/04/24 | 312 | +1.30% | 251,800 |
| 22/04/24 | 308 | -1.91% | 359,000 |
End-of-day quote INDONESIA S.E., April 25, 2024
More quotes
PT Bundamedik Tbk is an Indonesia-based company, which is engaged in hospital management. The Companyâs segments include Healthcare services and Others. The Company is a health care service provider that has medical technology at Bunda Jakarta Woman and Children Hospital, Bunda Jakarta General Hospital , Bunda Margonda General Hospital , Bunda Padang General Hospital, Bunda Ciputat Woman and Children Hospital, Bunda Citra Harapan General Hospital, AZ Zahra Woman and Children Hospital, BIC Pacific Place & BIC Vida Bekasi, Morula IVF (In Vitro Fertilization) Indonesia, Diagnos (Laboratory), Bunda Global Pharma, Emergency Response (ER), Bunda Diklat Indonesia, IRSI (Indonesian Reproductive Sciences Institute), Prima Dental, Indonesia Medical Tourism Board (IMTB) and Daima Norwood Menteng. Its subsidiaries include T Citra Ananda, PT Bunda Medika Wisesa, PT Visiscan Indonesia, PT Bunda Medika Dewata, and PT Sasana Mitra Bunda.
Calendar
20/05/2024
- Q1 2024 Earnings Release (Projected)
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
312
IDR
Average target price
340
IDR
Spread / Average Target
+8.97%
Chiffre d''affaires - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -4.29% | 165M | |
| -14.92% | 84.68B | |
| +13.30% | 81.12B | |
| +10.92% | 29.4B | |
| -12.71% | 16.73B | |
| -3.06% | 16.36B | |
| -2.63% | 14.92B | |
| -31.75% | 11.77B | |
| -1.42% | 11.72B | |
| +27.44% | 11.71B |
- Stock Market
- Equities
- BMHS Stock
